Multicenter evaluation of left ventricular assist device implantation with or without ECMO bridge in cardiogenic shock.

Higher mortality was observed with ECMO as a bridge to LVAD, likely due to higher acuity illness, yet acceptable one-year survival was seen compared with historical rates. The receipt of the HM3 was associated with improved survival compared with older generation devices.